Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis.
Hua L, Liang S, Zhou Y, Wu X, Cai H, Liu Z, Ou Y, Chen Y, Chen X, Yan Y, Wu D, Sun P, Hu W, Yang Z.
Hua L, et al. Among authors: wu x, wu d.
Int Immunopharmacol. 2022 Dec;113(Pt B):109431. doi: 10.1016/j.intimp.2022.109431. Epub 2022 Nov 13.
Int Immunopharmacol. 2022.
PMID: 36384076